Free Trial

CRH (CRH) Financials

CRH logo
$113.23 -0.01 (-0.01%)
Closing price 03:59 PM Eastern
Extended Trading
$113.19 -0.04 (-0.04%)
As of 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for CRH

Annual Income Statements for CRH

This table shows CRH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
685 1,280 2,240 2,889 - 1,304 2,630 3,862 3,178 3,492
Consolidated Net Income / (Loss)
792 1,336 2,305 2,889 1,738 1,165 2,686 3,889 3,072 3,521
Net Income / (Loss) Continuing Operations
700 1,251 2,010 1,526 - 1,009 2,507 2,699 3,072 3,521
Total Pre-Tax Income
1,000 1,704 2,024 1,993 - 1,454 3,102 3,461 4,014 4,714
Total Operating Income
1,267 2,007 2,315 2,446 - 2,026 3,327 3,809 4,186 4,925
Total Gross Profit
7,240 8,651 8,863 9,058 9,273 8,565 9,827 10,815 11,963 12,701
Total Revenue
23,259 26,078 26,011 27,424 - 25,888 29,206 32,723 34,949 35,572
Operating Revenue
23,259 26,078 26,011 27,424 - 25,888 29,206 32,723 34,949 35,572
Total Cost of Revenue
16,019 17,427 17,148 18,391 - 17,323 19,379 21,908 22,986 22,871
Operating Cost of Revenue
16,019 17,427 17,148 18,391 - 17,323 19,379 21,908 22,986 22,871
Total Operating Expenses
5,973 6,643 6,548 6,612 - 6,539 6,500 7,006 7,777 7,776
Selling, General & Admin Expense
- - - - - - 6,538 7,056 7,486 7,852
Impairment Charge
- - - - - - 0.00 0.00 357 161
Other Special Charges / (Income)
- - - - - - -38 -50 -66 -237
Total Other Income / (Expense), net
-375 -359 -356 -453 - -589 -225 -348 -172 -211
Interest Expense
431 411 362 - - 438 315 344 376 612
Interest & Investment Income
8.69 8.42 14 - - 0.00 0.00 65 206 143
Other Income / (Expense), net
48 44 -8.41 -453 - -151 90 -69 -2.00 258
Income Tax Expense
300 453 14 467 - 445 650 762 925 1,085
Other Gains / (Losses), net
- - - - - - 55 0.00 -17 -108
Net Income / (Loss) Discontinued Operations
92 85 296 1,388 - 312 179 1,190 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - 56 27 -106 29
Basic Earnings per Share
$0.89 $1.50 $2.72 - - $1.43 $3.35 $5.15 $4.36 $5.06
Weighted Average Basic Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 780.20M 758.30M 723.90M 683.30M
Diluted Earnings per Share
$0.89 $1.49 $2.71 - - $1.42 $3.32 $5.11 $4.33 $5.02
Weighted Average Diluted Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 786.80M 764.10M 729.20M 689.50M
Weighted Average Basic & Diluted Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 774.14M 752.14M 690.36M 676.48M
Cash Dividends to Common per Share
- - - - - - $1.21 $1.27 $1.33 $1.40

Quarterly Income Statements for CRH

This table shows CRH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
-28 1,199 1,306 701 116 1,297 1,376 703 -94 1,319
Consolidated Net Income / (Loss)
-31 1,212 1,318 573 114 1,309 1,389 709 -98 1,332
Net Income / (Loss) Continuing Operations
-31 1,212 1,318 573 114 1,309 1,389 709 -98 1,332
Total Pre-Tax Income
-39 1,578 1,720 755 99 1,733 1,895 987 -146 1,756
Total Operating Income
2.00 1,613 1,788 783 28 1,829 1,964 1,104 18 1,935
Total Gross Profit
1,619 3,630 3,763 2,951 1,807 3,675 4,059 3,160 1,837 4,026
Total Revenue
6,427 9,709 10,128 8,685 6,533 9,654 10,515 8,870 6,756 10,206
Operating Revenue
6,427 9,709 10,128 8,685 6,533 9,654 10,515 8,870 6,756 10,206
Total Cost of Revenue
4,808 6,079 6,365 5,734 4,726 5,979 6,456 5,710 4,919 6,180
Operating Cost of Revenue
4,808 6,079 6,365 5,734 4,726 5,979 6,456 5,710 4,919 6,180
Total Operating Expenses
1,617 2,017 1,975 2,168 1,779 1,846 2,095 2,056 1,819 2,091
Selling, General & Admin Expense
1,622 2,035 1,990 1,839 1,787 1,948 2,184 1,933 1,833 2,120
Other Special Charges / (Income)
-5.00 -18 -15 -28 -8.00 -102 -89 -38 -14 -29
Total Other Income / (Expense), net
-41 -35 -68 -28 71 -96 -69 -117 -164 -179
Interest Expense
81 73 131 91 133 155 164 160 181 200
Interest & Investment Income
40 36 62 68 43 36 33 31 37 30
Other Income / (Expense), net
0.00 2.00 1.00 -5.00 161 23 62 12 -20 -9.00
Income Tax Expense
-14 379 416 144 -19 430 531 143 -58 425
Other Gains / (Losses), net
-6.00 13 14 -38 -4.00 6.00 25 -135 -10 1.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-3.00 13 12 -128 -2.00 12 13 6.00 -4.00 13
Basic Earnings per Share
($0.05) $1.63 $1.81 $0.97 $0.16 $1.89 $1.99 $1.02 ($0.15) $1.95
Weighted Average Basic Shares Outstanding
742.90M 734.70M 718.20M 723.90M 687.80M 685.50M 681.60M 683.30M 676.70M 674.80M
Diluted Earnings per Share
($0.05) $1.62 $1.80 $0.96 $0.16 $1.88 $1.97 $1.01 ($0.15) $1.94
Weighted Average Diluted Shares Outstanding
742.90M 738.20M 722.10M 729.20M 693.40M 688.80M 685.50M 689.50M 676.70M 677.70M
Weighted Average Basic & Diluted Shares Outstanding
- - - 690.36M 686.68M 682.78M 679.34M 676.48M 676.00M 672.66M

Annual Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-4,181 -4,133 -5,388 -5,946 1,552 3,466 -1,938 153 454 -2,631
Net Cash From Operating Activities
1,057 -1,510 -2,392 -3,885 3,881 4,116 3,979 3,800 5,017 4,989
Net Cash From Continuing Operating Activities
1,057 -1,510 -2,392 -3,885 2,580 4,116 3,979 3,800 5,017 4,989
Net Income / (Loss) Continuing Operations
0.00 0.00 0.00 0.00 2,181 1,165 2,686 3,889 3,072 3,521
Consolidated Net Income / (Loss)
- - - - 2,181 1,165 2,686 3,889 3,072 3,521
Depreciation Expense
916 1,061 1,208 1,265 1,721 1,624 1,551 1,577 1,633 1,798
Non-Cash Adjustments To Reconcile Net Income
205 -2,511 -3,285 -4,539 -1,024 1,185 27 -1,242 547 -14
Changes in Operating Assets and Liabilities, net
-64 -60 -315 -611 -364 142 -285 -424 -235 -316
Net Cash From Investing Activities
-8,886 -1,054 -3,466 -5,400 217 -1,347 -2,513 -917 -2,391 -6,291
Net Cash From Continuing Investing Activities
-8,886 -1,054 -3,466 -5,400 -2,040 -1,347 -2,513 -917 -2,397 -6,291
Purchase of Property, Plant & Equipment
- - -1,254 -1,324 -1,374 -996 -1,554 -1,523 -1,817 -2,578
Acquisitions
- - -2,211 -4,076 -727 -351 -1,494 -3,253 -640 -4,900
Purchase of Investments
- - - - - - 0.00 -11 -1.00 -9.00
Sale of Property, Plant & Equipment
-958 -897 - - - - 387 115 104 272
Divestitures
-7,927 -157 - - - - 120 3,712 0.00 1,001
Sale and/or Maturity of Investments
- - - - 39 - 32 36 44 44
Other Investing Activities, net
- - - - 22 - -4.00 7.00 -87 -121
Net Cash From Financing Activities
3,648 -1,570 470 3,339 2,546 697 -3,107 -2,499 -2,380 -1,186
Net Cash From Continuing Financing Activities
3,648 -1,570 470 3,339 -2,485 697 -3,107 -2,499 -2,378 -1,186
Repayment of Debt
-41 0.00 -434 -291 -996 -4,943 -1,183 -364 -1,462 -1,859
Repurchase of Common Equity
- - -3.60 -921 -954 -249 -896 -1,178 -3,067 -1,482
Payment of Dividends
-416 -379 -573 -633 -663 -722 -946 -943 -975 -1,740
Issuance of Debt
4,105 -1,191 1,480 5,184 106 6,611 0.00 38 3,163 4,001
Other Financing Activities, net
- - - - 22 - -82 -52 -37 -106
Effect of Exchange Rate Changes
- - - - - - -297 -231 208 -143
Cash Interest Paid
328 364 381 394 - 432 340 329 418 599
Cash Income Taxes Paid
- - - - - - 642 1,043 959 960

Quarterly Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
-1,286 -375 1,447 668 -3,081 637 -866 679 -407 -476
Net Cash From Operating Activities
-671 1,634 1,631 2,423 -712 1,485 1,486 2,730 -659 1,378
Net Cash From Continuing Operating Activities
-671 1,634 1,631 2,423 -712 1,485 1,486 2,730 -659 1,378
Net Income / (Loss) Continuing Operations
-31 1,212 1,318 573 114 1,309 1,389 709 -98 1,332
Consolidated Net Income / (Loss)
-31 1,212 1,318 573 114 1,309 1,389 709 -98 1,332
Depreciation Expense
384 401 402 446 397 424 467 510 477 528
Non-Cash Adjustments To Reconcile Net Income
36 44 16 451 -105 -80 -155 326 16 42
Changes in Operating Assets and Liabilities, net
-1,060 -23 -105 953 -1,118 -168 -215 1,185 -1,054 -524
Net Cash From Investing Activities
-492 -478 -759 -662 -2,096 -521 -1,788 -1,886 -964 -831
Net Cash From Continuing Investing Activities
-492 -478 -759 -668 -2,096 -521 -1,788 -1,886 -964 -831
Purchase of Property, Plant & Equipment
-332 -439 -404 -642 -506 -624 -505 -943 -645 -655
Acquisitions
-155 -43 -363 -79 -2,206 -316 -1,331 -1,047 -585 -63
Purchase of Investments
-2.00 9.00 -4.00 -4.00 -13 10 -18 12 20 -53
Sale of Property, Plant & Equipment
6.00 36 22 40 10 357 84 -908 35 30
Divestitures
- - 5.00 -5.00 729 - 27 919 36 1.00
Sale and/or Maturity of Investments
8.00 4.00 11 21 6.00 9.00 7.00 22 9.00 4.00
Other Investing Activities, net
-17 -45 -26 1.00 -116 -12 -52 59 166 -95
Net Cash From Financing Activities
-191 -1,555 649 -1,283 -176 -339 -629 -42 1,141 -1,153
Net Cash From Continuing Financing Activities
-191 -1,555 649 -1,281 -176 -339 -629 -42 1,141 -1,153
Repayment of Debt
0.00 -849 -91 -522 -651 -1,040 -163 -5.00 -1,533 -1,819
Repurchase of Common Equity
-246 -713 -1,072 -1,036 -559 -348 -317 -258 -310 -334
Payment of Dividends
-13 -771 -12 -179 -767 -486 -249 -238 -17 -503
Issuance of Debt
71 784 1,832 476 1,818 1,552 82 549 3,017 1,525
Other Financing Activities, net
-3.00 -6.00 -8.00 -20 -17 -17 18 -90 -16 -22
Effect of Exchange Rate Changes
68 24 -74 190 -97 12 65 -123 75 130
Cash Interest Paid
54 147 43 174 45 171 156 227 63 188
Cash Income Taxes Paid
104 173 343 339 159 145 350 306 134 170

Annual Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
33,237 37,999 46,777 47,612 44,944 44,670 45,319 47,469 50,613
Total Current Assets
9,882 11,737 17,395 17,258 14,977 14,044 14,833 16,885 14,083
Cash & Equivalents
2,576 2,541 9,191 9,918 7,721 5,783 5,936 6,341 3,720
Restricted Cash
- - - - - - - 0.00 39
Accounts Receivable
4,186 4,361 4,665 4,231 4,086 4,569 4,300 4,507 4,820
Inventories, net
3,092 3,261 3,505 3,080 3,117 3,611 4,194 4,291 4,755
Other Current Assets
- - - - - - 403 478 749
Other Current Nonoperating Assets
- - - - - - - 1,268 0.00
Plant, Property, & Equipment, net
13,350 15,729 18,046 19,574 19,317 19,502 17,768 17,841 21,452
Total Noncurrent Assets
10,005 10,533 11,336 10,780 10,650 11,124 12,718 12,743 15,078
Long-Term Investments
1,367 1,499 1,332 775 626 653 649 620 737
Goodwill
- - - - - - 9,199 9,158 11,061
Intangible Assets
8,165 8,666 9,656 9,475 9,373 9,848 1,088 1,041 1,211
Other Noncurrent Operating Assets
83 66 60 98 197 275 1,782 1,924 2,069
Total Liabilities & Shareholders' Equity
33,237 37,999 46,777 47,612 44,944 44,670 45,319 47,469 50,613
Total Liabilities
18,043 20,008 27,825 27,977 24,596 23,756 22,279 25,848 27,763
Total Current Liabilities
6,690 7,516 14,006 13,411 7,465 7,581 8,041 10,013 10,296
Short-Term Debt
289 380 7,213 6,616 1,257 549 1,491 1,866 2,999
Accounts Payable
5,550 5,718 5,817 5,461 5,503 6,409 2,930 3,149 3,207
Accrued Expenses
- - - - - - 2,132 2,296 2,248
Other Current Liabilities
436 869 468 769 797 790 1,488 2,327 1,842
Other Current Nonoperating Liabilities
- - - - - - 0.00 375 0.00
Total Noncurrent Liabilities
11,353 12,492 13,819 14,566 17,131 16,175 14,238 15,835 17,467
Long-Term Debt
7,906 9,202 9,959 9,211 10,958 9,938 8,145 9,776 10,969
Noncurrent Deferred & Payable Income Tax Liabilities
2,112 2,001 2,530 2,627 2,613 2,734 2,885 2,738 3,105
Other Noncurrent Operating Liabilities
713 836 844 855 954 937 3,208 3,321 3,393
Commitments & Contingencies
- - - - - - 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - 308 333 384
Total Equity & Noncontrolling Interests
15,193 17,990 18,951 19,634 20,347 20,914 22,732 21,288 22,466
Total Preferred & Common Equity
14,616 17,406 18,349 19,027 40,004 20,233 22,157 20,854 21,607
Preferred Stock
- - - - 7,493 - 1.00 1.00 1.00
Total Common Equity
14,616 17,406 18,349 19,027 12,162 20,232 22,156 20,853 21,606
Common Stock
299 344 352 335 333 309 745 750 712
Retained Earnings
6,809 9,493 11,705 11,350 11,565 19,770 22,495 22,918 24,036
Treasury Stock
-15 -18 -920 -360 -386 -195 -297 -2,199 -2,137
Accumulated Other Comprehensive Income / (Loss)
- - - - - - -787 -616 -1,005
Noncontrolling Interest
576 584 602 607 692 681 575 434 859

Quarterly Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025
Total Assets
45,107 46,142 47,631 46,333 48,105 51,221 51,921 53,984
Total Current Assets
14,230 15,074 16,315 13,709 15,113 14,840 14,242 15,151
Cash & Equivalents
4,650 4,275 5,722 3,308 3,066 2,978 3,352 2,876
Restricted Cash
- 0.00 0.00 0.00 869 102 0.00 0.00
Accounts Receivable
4,706 6,119 5,972 4,798 5,893 6,422 5,141 6,490
Inventories, net
4,458 4,276 4,191 4,619 4,514 4,644 4,960 5,051
Other Current Assets
416 404 430 748 704 694 789 734
Other Current Nonoperating Assets
0.00 0.00 0.00 236 67 0.00 0.00 0.00
Plant, Property, & Equipment, net
17,997 18,155 18,103 18,878 19,235 21,289 22,179 23,017
Total Noncurrent Assets
12,880 12,913 13,213 13,746 13,757 15,092 15,500 15,816
Long-Term Investments
655 672 665 609 484 929 732 712
Goodwill
9,308 9,338 9,545 10,125 10,251 10,906 11,475 11,673
Intangible Assets
1,094 1,061 1,074 1,093 1,086 1,105 1,208 1,239
Other Noncurrent Operating Assets
1,823 1,842 1,929 1,919 1,936 2,152 2,085 2,192
Total Liabilities & Shareholders' Equity
45,107 46,142 47,631 46,333 48,105 51,221 51,921 53,984
Total Liabilities
22,963 23,433 24,983 25,591 26,654 28,055 29,564 30,354
Total Current Liabilities
9,255 9,671 9,191 9,997 10,548 10,668 8,712 8,684
Short-Term Debt
2,251 2,185 1,860 2,992 3,218 3,218 1,458 1,171
Accounts Payable
2,627 3,553 2,954 2,730 3,363 2,963 2,777 3,303
Accrued Expenses
2,079 2,335 2,457 2,241 2,272 2,513 2,270 2,266
Other Current Liabilities
2,298 1,598 1,920 1,990 1,681 1,974 2,207 1,944
Other Current Nonoperating Liabilities
0.00 0.00 0.00 44 14 0.00 0.00 0.00
Total Noncurrent Liabilities
13,708 13,762 15,792 15,594 16,106 17,387 20,852 21,670
Long-Term Debt
7,583 7,563 9,535 9,680 9,900 10,672 14,213 14,642
Noncurrent Deferred & Payable Income Tax Liabilities
2,972 3,010 3,050 2,684 2,914 3,168 3,141 3,202
Other Noncurrent Operating Liabilities
3,153 3,189 3,207 3,230 3,292 3,547 3,498 3,826
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
307 313 320 326 335 361 379 389
Total Equity & Noncontrolling Interests
21,837 22,396 22,328 20,416 21,116 22,805 21,978 23,241
Total Preferred & Common Equity
21,255 21,821 21,767 20,015 20,726 21,875 21,119 22,345
Preferred Stock
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Total Common Equity
21,254 21,820 21,766 20,014 20,725 21,874 21,118 22,344
Common Stock
722 693 725 631 651 683 587 611
Retained Earnings
21,692 22,892 23,936 22,346 23,030 23,831 23,375 24,106
Treasury Stock
-487 -1,140 -2,132 -2,166 -2,143 -2,141 -2,038 -2,028
Accumulated Other Comprehensive Income / (Loss)
-673 -625 -763 -797 -813 -499 -806 -345
Noncontrolling Interest
582 575 561 401 390 930 859 896

Annual Metrics And Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 12.12% -0.26% 11.93% 0.00% 0.00% 12.82% 12.04% 6.80% 1.78%
EBITDA Growth
0.00% 39.55% 12.91% 23.68% -45.15% 95.80% 41.98% 7.03% 9.40% 20.01%
EBIT Growth
0.00% 56.03% 12.43% 8.61% -100.00% 0.00% 82.24% 9.45% 11.87% 23.88%
NOPAT Growth
0.00% 66.12% 56.01% 3.17% -100.00% 0.00% 87.05% 12.95% 8.45% 17.70%
Net Income Growth
0.00% 68.67% 72.54% -2.85% -39.84% -32.97% 130.56% 44.79% -21.01% 14.62%
EPS Growth
0.00% 68.09% 81.60% 39.60% 0.00% 0.00% 133.80% 53.92% -15.26% 15.94%
Operating Cash Flow Growth
0.00% -242.79% -58.43% 75.23% 199.90% 6.06% -3.33% -4.50% 32.03% -0.56%
Free Cash Flow Firm Growth
0.00% 0.00% 97.57% 0.00% 63.29% 454.28% -7.67% 70.22% 22.77% -179.97%
Invested Capital Growth
0.00% 0.00% 14.08% 0.00% 2.23% -2.36% 2.98% -0.79% -2.61% 27.21%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.52%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.11%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.98%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.69%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.02%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.01%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.56%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.19%
Profitability Metrics
- - - - - - - - - -
Gross Margin
31.13% 33.17% 34.07% 32.99% 0.00% 33.08% 33.65% 33.05% 34.23% 35.71%
EBITDA Margin
9.59% 11.94% 13.51% 37.80% 0.00% 13.52% 17.01% 16.25% 16.64% 19.63%
Operating Margin
5.45% 7.70% 8.90% 33.19% 0.00% 7.83% 11.39% 11.64% 11.98% 13.85%
EBIT Margin
5.65% 7.87% 8.87% 33.19% 0.00% 7.24% 11.70% 11.43% 11.97% 14.57%
Profit (Net Income) Margin
3.41% 5.12% 8.86% 37.08% 0.00% 4.50% 9.20% 11.88% 8.79% 9.90%
Tax Burden Percent
79.24% 78.40% 113.89% 112.37% 0.00% 80.12% 86.59% 112.37% 76.53% 74.69%
Interest Burden Percent
76.03% 83.08% 87.76% 99.40% 0.00% 77.55% 90.78% 92.54% 95.94% 90.95%
Effective Tax Rate
30.00% 26.60% 0.71% 5.16% 0.00% 30.61% 20.95% 22.02% 23.04% 23.02%
Return on Invested Capital (ROIC)
0.00% 15.17% 11.06% 67.70% 0.00% 5.44% 10.15% 11.34% 12.51% 13.13%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 8.68% 11.22% 89.56% 0.00% 1.33% 11.21% 33.12% 8.14% 9.06%
Return on Net Nonoperating Assets (RNNOA)
0.00% 2.42% 2.84% 0.00% 0.00% 0.39% 2.87% 6.36% 1.25% 2.70%
Return on Equity (ROE)
0.00% 17.59% 13.89% 0.00% 9.01% 5.83% 13.02% 17.70% 13.76% 15.84%
Cash Return on Invested Capital (CROIC)
0.00% -184.83% -2.09% -132.30% -2.21% 7.83% 7.21% 12.14% 15.16% -10.81%
Operating Return on Assets (OROA)
0.00% 6.17% 6.48% 22.63% 0.00% 4.05% 7.63% 8.31% 9.02% 10.57%
Return on Assets (ROA)
0.00% 4.02% 6.47% 25.28% 0.00% 2.52% 5.99% 8.64% 6.62% 7.18%
Return on Common Equity (ROCE)
0.00% 16.92% 13.41% 0.00% 8.73% 4.55% 10.22% 17.07% 13.25% 15.12%
Return on Equity Simple (ROE_SIMPLE)
0.00% 9.14% 13.24% 93.65% 9.13% 2.91% 13.28% 17.55% 14.73% 16.30%
Net Operating Profit after Tax (NOPAT)
887 1,473 2,298 8,648 0.00 1,406 2,630 2,970 3,221 3,791
NOPAT Margin
3.81% 5.65% 8.84% 31.48% 0.00% 5.43% 9.00% 9.08% 9.22% 10.66%
Net Nonoperating Expense Percent (NNEP)
0.00% 6.49% -0.16% -21.86% -26.43% 4.11% -1.06% -21.78% 4.37% 4.08%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.18% 9.78% 10.41%
Cost of Revenue to Revenue
68.87% 66.83% 65.93% 67.01% 0.00% 66.92% 66.35% 66.95% 65.77% 64.30%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.39% 21.56% 21.42% 22.07%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
25.68% 25.48% 25.17% -0.21% 0.00% 25.26% 22.26% 21.41% 22.25% 21.86%
Earnings before Interest and Taxes (EBIT)
1,315 2,051 2,306 9,119 0.00 1,875 3,417 3,740 4,184 5,183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,231 3,113 3,515 10,385 1,787 3,499 4,968 5,317 5,817 6,981
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 1.65 2.68 2.03 1.30 2.46 2.91
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 3.29 11.67 3.96 2.43 4.81 6.73
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 1.26 1.41 0.88 1.46 1.77
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 24.95 15.65 7.46 16.11 18.00
Dividend Yield
2.84% 2.38% 2.27% 3.25% 2.15% 2.23% 2.26% 0.00% 1.95% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 4.01% 6.39% 13.41% 6.21% 5.56%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.28 1.48 1.80 1.80 1.25 2.23 2.28
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.26 0.00 1.77 1.62 1.00 1.62 2.07
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.70 21.60 13.12 9.51 6.16 9.74 10.54
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.80 0.00 24.49 13.82 8.75 13.54 14.19
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.84 0.00 32.65 17.96 11.02 17.58 19.40
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 1.03 9.95 11.15 11.87 8.62 11.29 14.75
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 22.69 25.28 10.30 14.51 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.54 0.53 0.93 0.88 0.67 0.57 0.42 0.54 0.61
Long-Term Debt to Equity
0.00 0.52 0.51 0.00 0.54 0.60 0.54 0.35 0.45 0.48
Financial Leverage
0.00 0.28 0.25 0.00 0.34 0.29 0.26 0.19 0.15 0.30
Leverage Ratio
0.00 2.19 2.15 3.51 2.45 2.32 2.17 2.05 2.08 2.21
Compound Leverage Factor
0.00 1.82 1.88 3.49 0.00 1.80 1.97 1.89 1.99 2.01
Debt to Total Capital
0.00% 35.04% 34.75% 48.18% 46.72% 39.98% 36.19% 29.49% 35.00% 37.94%
Short-Term Debt to Total Capital
0.00% 1.24% 1.38% 48.18% 17.95% 3.71% 1.68% 4.56% 5.61% 8.15%
Long-Term Debt to Total Capital
0.00% 33.80% 33.37% 0.00% 28.77% 36.27% 34.51% 24.93% 29.39% 29.79%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 22.10% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 2.46% 2.12% 2.72% 1.65% 2.04% 2.08% 2.70% 2.31% 3.38%
Common Equity to Total Capital
0.00% 62.50% 63.13% 49.10% 51.63% 35.88% 61.73% 67.81% 62.69% 58.68%
Debt to EBITDA
0.00 2.63 2.73 1.03 9.64 3.87 2.39 1.81 2.00 2.00
Net Debt to EBITDA
0.00 1.36 1.56 0.64 3.65 1.48 1.08 0.57 0.80 1.36
Long-Term Debt to EBITDA
0.00 2.54 2.62 0.00 5.93 3.51 2.28 1.53 1.68 1.57
Debt to NOPAT
0.00 5.56 4.17 1.23 0.00 9.64 4.51 3.24 3.61 3.68
Net Debt to NOPAT
0.00 2.87 2.39 0.77 0.00 3.69 2.05 1.03 1.45 2.50
Long-Term Debt to NOPAT
0.00 5.37 4.00 0.00 0.00 8.75 4.30 2.74 3.03 2.89
Altman Z-Score
0.00 0.00 0.00 1.65 1.11 2.07 2.74 2.64 3.07 3.15
Noncontrolling Interest Sharing Ratio
0.00% 3.79% 3.50% 0.00% 3.13% 21.99% 21.49% 3.56% 3.70% 4.52%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 1.48 1.56 0.66 1.29 2.01 1.85 1.84 1.69 1.37
Quick Ratio
0.00 1.01 0.92 0.45 1.06 1.58 1.37 1.27 1.08 0.83
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -17,949 -435 -16,900 -571 2,023 1,868 3,179 3,903 -3,122
Operating Cash Flow to CapEx
110.32% -168.23% -190.71% 0.00% 282.46% 413.25% 340.96% 269.89% 292.88% 216.35%
Free Cash Flow to Firm to Interest Expense
0.00 -43.64 -1.20 -310.90 0.00 4.62 5.93 9.24 10.38 -5.10
Operating Cash Flow to Interest Expense
2.45 -3.67 -6.61 129.65 0.00 9.40 12.63 11.05 13.34 8.15
Operating Cash Flow Less CapEx to Interest Expense
0.23 -5.85 -10.08 154.02 0.00 7.12 8.93 6.95 8.79 4.38
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.78 0.73 0.68 0.00 0.56 0.65 0.73 0.75 0.73
Accounts Receivable Turnover
0.00 6.23 6.09 5.64 0.00 6.23 6.75 7.38 7.94 7.63
Inventory Turnover
0.00 5.64 5.40 5.25 0.00 5.59 5.76 5.61 5.42 5.06
Fixed Asset Turnover
0.00 1.95 1.79 1.52 0.00 1.33 1.50 1.76 1.96 1.81
Accounts Payable Turnover
0.00 3.14 3.04 3.49 0.00 3.16 3.25 4.69 7.56 7.20
Days Sales Outstanding (DSO)
0.00 58.59 59.97 64.76 0.00 58.63 54.08 49.46 45.99 47.85
Days Inventory Outstanding (DIO)
0.00 64.76 67.62 69.53 0.00 65.29 63.36 65.02 67.37 72.18
Days Payable Outstanding (DPO)
0.00 116.25 119.93 104.69 0.00 115.51 112.18 77.80 48.26 50.72
Cash Conversion Cycle (CCC)
0.00 7.10 7.66 29.60 0.00 8.41 5.26 36.68 65.09 69.32
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 19,422 22,156 25,548 26,155 25,538 26,300 26,091 25,409 32,322
Invested Capital Turnover
0.00 2.69 1.25 2.15 0.00 1.00 1.13 1.25 1.36 1.23
Increase / (Decrease) in Invested Capital
0.00 19,422 2,734 25,548 571 -617 762 -209 -682 6,913
Enterprise Value (EV)
0.00 0.00 0.00 7,254 38,598 45,909 47,228 32,740 56,643 73,568
Market Capitalization
0.00 0.00 0.00 0.00 31,471 32,534 41,161 28,805 51,194 62,852
Book Value per Share
$0.00 $0.00 $20.75 $0.00 $22.56 $15.21 $25.44 $29.22 $27.72 $31.80
Tangible Book Value per Share
$0.00 $0.00 $10.42 $0.00 $11.33 $3.49 $13.06 $15.65 $14.16 $13.74
Total Capital
0.00 23,388 27,571 22,150 36,854 33,901 32,775 32,676 33,263 36,818
Total Debt
0.00 8,195 9,581 10,672 17,220 13,554 11,861 9,636 11,642 13,968
Total Long-Term Debt
0.00 7,906 9,202 0.00 10,604 12,297 11,312 8,145 9,776 10,969
Net Debt
0.00 4,228 5,501 6,652 6,520 5,190 5,386 3,051 4,681 9,472
Capital Expenditures (CapEx)
958 897 1,254 -1,325 1,374 996 1,167 1,408 1,713 2,306
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 882 2,019 2,189 538 1,031 1,190 2,347 2,397 3,027
Debt-free Net Working Capital (DFNWC)
0.00 3,482 4,601 4,877 10,463 8,769 7,012 8,283 8,738 6,786
Net Working Capital (NWC)
0.00 3,193 4,221 -5,796 3,847 7,512 6,463 6,792 6,872 3,787
Net Nonoperating Expense (NNE)
95 137 -6.88 -1,538 -1,738 241 -56 -919 149 270
Net Nonoperating Obligations (NNO)
0.00 4,229 4,166 14,070 6,521 5,191 5,386 3,051 3,788 9,472
Total Depreciation and Amortization (D&A)
916 1,061 1,208 1,266 1,787 1,624 1,551 1,577 1,633 1,798
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 3.38% 7.76% 7.97% 0.00% 3.98% 4.07% 7.17% 6.86% 8.51%
Debt-free Net Working Capital to Revenue
0.00% 13.35% 17.69% 17.75% 0.00% 33.87% 24.01% 25.31% 25.00% 19.08%
Net Working Capital to Revenue
0.00% 12.24% 16.23% -21.10% 0.00% 29.02% 22.13% 20.76% 19.66% 10.65%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $2.27 $3.57 $2.41 $142.90 $0.00 $5.07 $4.36 $5.06
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 838.96M 0.00 799.64M 795.14M 0.00 752.14M 723.90M 683.30M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $2.25 $3.56 $2.39 $141.80 $0.00 $5.03 $4.33 $5.02
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 838.96M 0.00 799.64M 795.14M 0.00 752.14M 729.20M 689.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 838.96M 0.00 799.64M 795.14M 0.00 752.14M 690.36M 676.48M
Normalized Net Operating Profit after Tax (NOPAT)
887 1,473 2,298 8,648 0.00 1,406 2,600 2,931 3,445 3,733
Normalized NOPAT Margin
3.81% 5.65% 8.84% 31.48% 0.00% 5.43% 8.90% 8.96% 9.86% 10.49%
Pre Tax Income Margin
4.30% 6.54% 7.78% 33.00% 0.00% 5.62% 10.62% 10.58% 11.49% 13.25%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
3.05 4.99 6.38 167.76 0.00 4.28 10.85 10.87 11.13 8.47
NOPAT to Interest Expense
2.06 3.58 6.36 159.10 0.00 3.21 8.35 8.63 8.57 6.20
EBIT Less CapEx to Interest Expense
0.83 2.81 2.91 192.13 0.00 2.01 7.14 6.78 6.57 4.70
NOPAT Less CapEx to Interest Expense
-0.17 1.40 2.89 183.47 0.00 0.94 4.64 4.54 4.01 2.43
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
52.54% 28.35% 24.86% 6.18% 38.15% 61.97% 35.22% 24.25% 31.74% 49.42%
Augmented Payout Ratio
52.54% 28.35% 25.01% 15.37% 93.04% 83.35% 68.58% 54.54% 131.58% 91.51%

Quarterly Metrics And Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 1.65% -0.57% 3.82% 2.13% 3.41% 5.72%
EBITDA Growth
0.00% 0.00% 0.00% 0.00% 51.81% 12.90% 13.78% 32.84% -18.94% 7.82%
EBIT Growth
0.00% 0.00% 0.00% 0.00% 9,350.00% 14.67% 13.25% 43.44% -101.06% 4.00%
NOPAT Growth
0.00% 0.00% 0.00% 0.00% 2,283.84% 12.21% 4.29% 48.98% -62.25% 6.65%
Net Income Growth
0.00% 0.00% 0.00% 0.00% 467.74% 8.00% 5.39% 23.73% -185.96% 1.76%
EPS Growth
0.00% 0.00% 0.00% 0.00% 420.00% 16.05% 9.44% 5.21% -193.75% 3.19%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% -6.11% -9.12% -8.89% 12.67% 7.44% -7.21%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -78.03% -254.12%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 9.87% 9.40% 19.49% 27.21% 15.83% 19.13%
Revenue Q/Q Growth
0.00% 51.07% 4.32% -14.25% 0.00% 47.77% 8.92% -15.64% -23.83% 51.07%
EBITDA Q/Q Growth
0.00% 422.28% 8.68% -44.14% 0.00% 288.40% 9.53% -34.78% -70.79% 416.63%
EBIT Q/Q Growth
0.00% 80,650.00% 10.77% -56.51% 0.00% 879.89% 9.40% -44.92% -100.18% 96,400.00%
NOPAT Q/Q Growth
0.00% 87,442.41% 10.60% -53.25% 0.00% 4,020.55% 2.80% -33.22% -98.67% 11,540.29%
Net Income Q/Q Growth
0.00% 4,009.68% 8.75% -56.53% 0.00% 1,048.25% 6.11% -48.96% -113.82% 1,459.18%
EPS Q/Q Growth
0.00% 3,340.00% 11.11% -46.67% 0.00% 1,075.00% 4.79% -48.73% -114.85% 1,393.33%
Operating Cash Flow Q/Q Growth
0.00% 343.52% -0.18% 48.56% 0.00% 308.57% 0.07% 83.71% -124.14% 309.10%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 53.37% -228.21% -50.07% 22.49% 7.24%
Invested Capital Q/Q Growth
0.00% 3.14% 0.53% -8.12% 0.00% 2.70% 9.80% -2.19% 5.02% 5.63%
Profitability Metrics
- - - - - - - - - -
Gross Margin
25.19% 37.39% 37.15% 33.98% 27.66% 38.07% 38.60% 35.63% 27.19% 39.45%
EBITDA Margin
6.01% 20.76% 21.63% 14.09% 8.97% 23.58% 23.71% 18.33% 7.03% 24.04%
Operating Margin
0.03% 16.61% 17.65% 9.02% 0.43% 18.95% 18.68% 12.45% 0.27% 18.96%
EBIT Margin
0.03% 16.63% 17.66% 8.96% 2.89% 19.18% 19.27% 12.58% -0.03% 18.87%
Profit (Net Income) Margin
-0.48% 12.48% 13.01% 6.60% 1.75% 13.56% 13.21% 7.99% -1.45% 13.05%
Tax Burden Percent
79.49% 76.81% 76.63% 75.89% 115.15% 75.53% 73.30% 71.83% 67.12% 75.85%
Interest Burden Percent
-1,950.00% 97.71% 96.14% 97.04% 52.38% 93.57% 93.53% 88.44% 7,300.00% 91.17%
Effective Tax Rate
0.00% 24.02% 24.19% 19.07% -19.19% 24.81% 28.02% 14.49% 0.00% 24.20%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 10.04% 0.64% 17.31% 15.67% 13.12% 0.21% 15.84%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 8.43% 1.87% 16.32% 15.34% 9.57% -0.89% 14.55%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 1.48% 0.57% 4.97% 4.99% 2.85% -0.41% 6.74%
Return on Equity (ROE)
0.00% 0.00% 0.00% 11.51% 1.21% 22.28% 20.66% 15.97% -0.20% 22.58%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 15.36% 0.00% 0.00% 0.00% -10.81% -2.76% -5.76%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 6.75% 2.22% 14.25% 13.79% 9.13% -0.02% 13.44%
Return on Assets (ROA)
0.00% 0.00% 0.00% 4.97% 1.34% 10.07% 9.46% 5.80% -1.06% 9.29%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 11.09% 1.17% 21.47% 19.68% 15.25% -0.19% 21.57%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 16.07% 15.99% 15.47% 0.00% 15.67% 0.00%
Net Operating Profit after Tax (NOPAT)
1.40 1,226 1,356 634 33 1,375 1,414 944 13 1,467
NOPAT Margin
0.02% 12.62% 13.38% 7.30% 0.51% 14.24% 13.44% 10.64% 0.19% 14.37%
Net Nonoperating Expense Percent (NNEP)
0.72% 0.28% 0.75% 1.60% -1.23% 0.98% 0.33% 3.55% 1.10% 1.29%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.92% - - - 2.59% 0.03% 3.76%
Cost of Revenue to Revenue
74.81% 62.61% 62.85% 66.02% 72.34% 61.93% 61.40% 64.37% 72.81% 60.55%
SG&A Expenses to Revenue
25.24% 20.96% 19.65% 21.17% 27.35% 20.18% 20.77% 21.79% 27.13% 20.77%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
25.16% 20.77% 19.50% 24.96% 27.23% 19.12% 19.92% 23.18% 26.92% 20.49%
Earnings before Interest and Taxes (EBIT)
2.00 1,615 1,789 778 189 1,852 2,026 1,116 -2.00 1,926
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
386 2,016 2,191 1,224 586 2,276 2,493 1,626 475 2,454
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.70 1.83 1.83 2.46 2.98 2.48 2.89 2.91 2.82 2.78
Price to Tangible Book Value (P/TBV)
3.33 3.49 3.57 4.81 6.77 5.48 6.42 6.73 7.06 6.58
Price to Revenue (P/Rev)
0.00 0.00 0.00 1.46 1.70 1.47 1.79 1.77 1.66 1.71
Price to Earnings (P/E)
0.00 0.00 0.00 16.11 17.93 15.05 18.14 18.00 18.13 18.78
Dividend Yield
0.00% 0.00% 0.00% 1.95% 1.95% 2.71% 2.56% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 6.21% 5.58% 6.64% 5.51% 5.56% 5.52% 5.32%
Enterprise Value to Invested Capital (EV/IC)
1.56 1.66 1.65 2.23 2.36 2.02 2.25 2.28 2.13 2.11
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 1.62 1.97 1.74 2.11 2.07 2.02 2.08
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 9.74 11.47 9.70 11.32 10.54 10.53 10.72
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 13.54 15.79 13.22 15.38 14.19 14.49 14.92
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 17.58 21.06 17.76 21.35 19.40 19.21 19.59
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 11.29 13.87 12.62 15.91 14.75 14.35 15.31
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.44 0.43 0.50 0.54 0.61 0.61 0.60 0.61 0.70 0.67
Long-Term Debt to Equity
0.34 0.33 0.42 0.45 0.47 0.46 0.46 0.48 0.64 0.62
Financial Leverage
0.20 0.21 0.22 0.18 0.31 0.30 0.33 0.30 0.47 0.46
Leverage Ratio
2.04 2.03 2.10 2.08 2.13 2.13 2.16 2.21 2.28 2.26
Compound Leverage Factor
-39.72 1.99 2.02 2.02 1.12 2.00 2.02 1.95 166.42 2.06
Debt to Total Capital
30.75% 30.03% 33.47% 35.00% 37.92% 37.95% 37.48% 37.94% 41.21% 40.09%
Short-Term Debt to Total Capital
7.04% 6.73% 5.46% 5.61% 8.95% 9.31% 8.68% 8.15% 3.83% 2.97%
Long-Term Debt to Total Capital
23.71% 23.30% 28.01% 29.39% 28.97% 28.64% 28.80% 29.79% 37.38% 37.12%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.78% 2.74% 2.59% 2.31% 2.18% 2.10% 3.48% 3.38% 3.26% 3.26%
Common Equity to Total Capital
66.46% 67.23% 63.94% 62.69% 59.90% 59.95% 59.03% 58.68% 55.53% 56.65%
Debt to EBITDA
0.00 0.00 0.00 2.00 2.11 2.09 2.11 2.00 2.28 2.24
Net Debt to EBITDA
0.00 0.00 0.00 0.80 1.46 1.39 1.50 1.36 1.69 1.73
Long-Term Debt to EBITDA
0.00 0.00 0.00 1.68 1.61 1.58 1.62 1.57 2.07 2.08
Debt to NOPAT
0.00 0.00 0.00 3.61 3.86 3.82 3.98 3.68 4.16 4.10
Net Debt to NOPAT
0.00 0.00 0.00 1.45 2.67 2.54 2.83 2.50 3.08 3.17
Long-Term Debt to NOPAT
0.00 0.00 0.00 3.03 2.95 2.89 3.06 2.89 3.78 3.80
Altman Z-Score
0.00 0.00 0.00 2.83 2.94 2.80 2.92 2.89 2.66 2.79
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 3.70% 3.77% 3.66% 4.75% 4.52% 4.56% 4.46%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.54 1.56 1.78 1.69 1.37 1.43 1.39 1.37 1.63 1.74
Quick Ratio
1.01 1.07 1.27 1.08 0.81 0.85 0.88 0.83 0.97 1.08
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 0.00 -2,599 -1,212 -3,977 -5,969 -4,626 -4,291
Operating Cash Flow to CapEx
-205.83% 405.46% 426.96% 402.49% 0.00% 556.18% 352.97% 147.49% -108.03% 220.48%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 -19.54 -7.82 -24.25 -37.31 -25.56 -21.46
Operating Cash Flow to Interest Expense
-8.28 22.38 12.45 26.63 -5.35 9.58 9.06 17.06 -3.64 6.89
Operating Cash Flow Less CapEx to Interest Expense
-12.31 16.86 9.53 20.01 -3.60 7.86 6.49 5.49 -7.01 3.77
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.75 0.77 0.74 0.72 0.73 0.73 0.71
Accounts Receivable Turnover
0.00 0.00 0.00 7.94 7.38 5.83 5.71 7.63 7.20 5.87
Inventory Turnover
0.00 0.00 0.00 5.42 5.05 5.19 5.18 5.06 4.82 4.86
Fixed Asset Turnover
0.00 0.00 0.00 1.96 1.90 1.87 1.80 1.81 1.74 1.72
Accounts Payable Turnover
0.00 0.00 0.00 7.56 8.55 6.59 7.74 7.20 8.38 6.98
Days Sales Outstanding (DSO)
0.00 0.00 0.00 45.99 49.48 62.63 63.92 47.85 50.67 62.18
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 67.37 72.33 70.35 70.43 72.18 75.80 75.03
Days Payable Outstanding (DPO)
0.00 0.00 0.00 48.26 42.68 55.35 47.17 50.72 43.58 52.29
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 65.09 79.12 77.63 87.18 69.32 82.89 84.92
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
26,673 27,510 27,656 25,409 29,305 30,097 33,047 32,322 33,944 35,855
Invested Capital Turnover
0.00 0.00 0.00 1.38 1.25 1.22 1.17 1.23 1.13 1.10
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 0.00 2,632 2,587 5,391 6,913 4,639 5,758
Enterprise Value (EV)
41,537 45,573 45,711 56,643 69,033 60,912 74,494 73,568 72,336 75,568
Market Capitalization
36,118 39,883 39,821 51,194 59,550 51,487 63,321 62,852 59,510 62,057
Book Value per Share
$28.26 $29.01 $28.94 $27.72 $29.10 $30.18 $32.04 $31.80 $31.22 $33.05
Tangible Book Value per Share
$14.43 $15.18 $14.82 $14.16 $12.79 $13.67 $14.45 $13.74 $12.47 $13.95
Total Capital
31,978 32,457 34,043 33,263 33,414 34,569 37,056 36,818 38,028 39,443
Total Debt
9,834 9,748 11,395 11,642 12,672 13,118 13,890 13,968 15,671 15,813
Total Long-Term Debt
7,583 7,563 9,535 9,776 9,680 9,900 10,672 10,969 14,213 14,642
Net Debt
4,529 4,801 5,008 4,681 8,755 8,699 9,881 9,472 11,587 12,225
Capital Expenditures (CapEx)
326 403 382 602 -233 267 421 1,851 610 625
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,576 3,313 3,262 2,397 3,396 3,848 4,310 3,027 3,636 4,762
Debt-free Net Working Capital (DFNWC)
7,226 7,588 8,984 8,738 6,704 7,783 7,390 6,786 6,988 7,638
Net Working Capital (NWC)
4,975 5,403 7,124 6,872 3,712 4,565 4,172 3,787 5,530 6,467
Net Nonoperating Expense (NNE)
32 14 38 61 -81 66 25 235 111 135
Net Nonoperating Obligations (NNO)
4,529 4,801 5,008 3,788 8,563 8,646 9,881 9,472 11,587 12,225
Total Depreciation and Amortization (D&A)
384 401 402 446 397 424 467 510 477 528
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 6.86% 9.69% 10.99% 12.18% 8.51% 10.16% 13.10%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 25.00% 19.12% 22.24% 20.88% 19.08% 19.52% 21.01%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 19.66% 10.59% 13.04% 11.79% 10.65% 15.45% 17.79%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.97 $0.16 $1.89 $1.99 $1.02 ($0.15) $1.95
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 723.90M 687.80M 685.50M 681.60M 683.30M 676.70M 674.80M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.96 $0.16 $1.88 $1.97 $1.01 ($0.15) $1.94
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 729.20M 693.40M 688.80M 685.50M 689.50M 676.70M 677.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 690.36M 686.68M 682.78M 679.34M 676.48M 676.00M 672.66M
Normalized Net Operating Profit after Tax (NOPAT)
-2.10 1,212 1,344 611 14 1,298 1,350 912 2.80 1,445
Normalized NOPAT Margin
-0.03% 12.48% 13.27% 7.04% 0.21% 13.45% 12.84% 10.28% 0.04% 14.16%
Pre Tax Income Margin
-0.61% 16.25% 16.98% 8.69% 1.52% 17.95% 18.02% 11.13% -2.16% 17.21%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.02 22.12 13.66 8.55 1.42 11.95 12.35 6.98 -0.01 9.63
NOPAT to Interest Expense
0.02 16.79 10.35 6.96 0.25 8.87 8.62 5.90 0.07 7.33
EBIT Less CapEx to Interest Expense
-4.00 16.60 10.74 1.93 3.17 10.23 9.79 -4.59 -3.38 6.51
NOPAT Less CapEx to Interest Expense
-4.01 11.27 7.43 0.35 2.00 7.15 6.05 -5.67 -3.30 4.21
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 31.74% 53.81% 43.63% 49.72% 49.42% 29.92% 30.22%
Augmented Payout Ratio
0.00% 0.00% 0.00% 131.58% 158.87% 134.61% 116.48% 91.51% 67.18% 66.81%

Key Financial Trends

CRH's financial performance over the past four years shows a general trend of revenue and profit growth, with some fluctuations influenced by macroeconomic and operational factors.

Positive Highlights:

  • Operating revenue has increased from approximately $6.43 billion in Q1 2023 to $10.21 billion in Q2 2025, showing significant top-line growth over two years.
  • Net income attributable to common shareholders improved from a loss of $28 million in Q1 2023 to a profit of around $1.32 billion in Q2 2025, indicating a strong turnaround in profitability.
  • Gross profit margins have strengthened, with total gross profit rising from $1.62 billion in Q1 2023 to $4.03 billion in Q2 2025, pointing to better cost management or pricing power.
  • Depreciation expenses have increased, suggesting ongoing investment in fixed assets which could support future growth.
  • Cash and equivalents remained relatively stable and increased from about $3.3 billion in Q1 2024 to $2.9 billion in Q2 2025, preserving liquidity despite capital investments and debt repayments.
  • CRH has consistently generated positive net cash from operating activities in recent quarters, with $1.38 billion in Q2 2025 indicating solid operational cash flow generation.
  • The company has been actively repaying debt (e.g., $1.82 billion repaid in Q2 2025) while also managing debt issuance effectively to balance capital structure.
  • Issuance of equity has been low, indicating limited dilution pressure to shareholders along with active stock repurchasing supporting earnings per share growth.

Neutral Aspects:

  • Total assets increased from approximately $45 billion in early 2023 to about $54 billion in mid-2025, mainly driven by increases in plant, property, & equipment and goodwill, reflecting acquisitions and capital expenditures.
  • Liabilities also rose from about $23 billion to $30.3 billion over the same period, with a balanced increase in long-term debt and current liabilities, indicating leveraged growth strategy.
  • Interest expenses generally increased along with debt levels, but remain well-covered by operating income and interest income.
  • Changes in operating assets and liabilities have occasionally caused volatility in operating cash flows, notably a large negative impact of $1.05 billion in Q1 2025 reversed by a positive $524 million in Q2 2025.

Negative Considerations:

  • There was a notable loss in Q1 2025, with net income at a negative $98 million and negative operating cash flow of $659 million, signaling a challenging quarter likely due to operating headwinds or restructuring.
  • Capital expenditures and acquisitions represent significant cash outflows, e.g., $655 million spent on property, plant and equipment plus $63 million on acquisitions in Q2 2025, which may pressure free cash flow in the short term.
  • Repurchase of common equity remains substantial ($334 million in Q2 2025), which while supporting share price, reduces cash reserves.
  • Income tax expense has increased consistently, weighing on net profitability, with $425 million paid in Q2 2025.

Summary: CRH has demonstrated strong revenue and profit growth over recent years with robust operational cash flow and strategic investments in assets and acquisitions. The company has managed its capital structure by balancing debt repayments with new debt issuance and share repurchases. However, the loss and negative cash flow in Q1 2025 highlight some operational volatility possibly warranting further monitoring. Overall, the financial data suggest CRH is on a growth trajectory with essentially stable liquidity and improving profitability, supported by effective financial management.

08/28/25 05:37 PM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About CRH's Financials

When does CRH's fiscal year end?

According to the most recent income statement we have on file, CRH's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CRH's net income changed over the last 9 years?

CRH's net income appears to be on an upward trend, with a most recent value of $3.52 billion in 2024, rising from $792.09 million in 2015. The previous period was $3.07 billion in 2023. See CRH's forecast for analyst expectations on what’s next for the company.

What is CRH's operating income?
CRH's total operating income in 2024 was $4.93 billion, based on the following breakdown:
  • Total Gross Profit: $12.70 billion
  • Total Operating Expenses: $7.78 billion
How has CRH's revenue changed over the last 9 years?

Over the last 9 years, CRH's total revenue changed from $23.26 billion in 2015 to $35.57 billion in 2024, a change of 52.9%.

How much debt does CRH have?

CRH's total liabilities were at $27.76 billion at the end of 2024, a 7.4% increase from 2023, and a 53.9% increase since 2016.

How much cash does CRH have?

In the past 8 years, CRH's cash and equivalents has ranged from $2.54 billion in 2017 to $9.92 billion in 2019, and is currently $3.72 billion as of their latest financial filing in 2024.

How has CRH's book value per share changed over the last 9 years?

Over the last 9 years, CRH's book value per share changed from 0.00 in 2015 to 31.80 in 2024, a change of 3,180.5%.



This page (NYSE:CRH) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners